Home
Live Updates
Chroma Medicine Announces Data Demonstrating the Benefits of Epigenetic Editing for Multiplex Gene Regulation at ASGCT 2023 : vimarsana.com
Chroma Medicine Announces Data Demonstrating the Benefits of Epigenetic Editing for Multiplex Gene Regulation at ASGCT 2023
/PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Vic Myer ,
Los Angeles ,
Catherine Stehman Breen ,
Sahar Abubucker ,
Chroma Medicine Inc ,
American Society Of Gene Cell Therapy ,
American Society ,
Cell Therapy ,
Annual Meeting ,
Senior Director ,
Epigenome Editing ,
Chroma Medicine ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Biotechnology ,
Clinical Trials Amp Medical Discoveries ,
Trade Show News ,
vimarsana.com © 2020. All Rights Reserved.